Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Kramer

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1990
Hemodialysis clearance of intravenously administered ribavirinT H Kramer, G G Gaar, C G Ray, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouseE A Ayres, D N Parkhurst, S Fang, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
The effects of a centrally selective cholecystokinin analog on male, Sprague Dawley rats in the non-fasted food intake modelW S Wire, S N Fang, V J Hruby, et al.
Life Sciences|January 1, 1992
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphinA Misicka, A W Lipkowski, R Horvath, et al.
Life Sciences|January 1, 1991
Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitroT H Kramer, G Toth, R C Haaseth, et al.
Journal of Medicinal Chemistry|January 1, 1990
[D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptorsG Toth, T H Kramer, R Knapp, et al.
Proceedings of the Western Pharmacology Society|January 1, 1990
Evaluation of a food intake model as a tool for studying cholecystokinin (CCK) and derivatives of CCK in male Sprague-Dawley ratsW S Wire, S N Fang, V J Hruby, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivoT H Kramer, J E Shook, W Kazmierski, et al.
Gastroenterology|June 1, 1991
Changes in opioid receptor selectivity following processing of peptide E: effect on gut motilityT P Davis, T J Gillespie, J Shook, et al.
International Journal of Peptide and Protein Research|February 1, 1992
Synthesis and biological activities of linear and cyclic enkephalin analogues containing a psi (E,CH = CH) or psi (CH2CH2) isosteric replacementD Tourwé, J Couder, M Ceusters, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|March 1, 1990
Hemodialysis clearance of intravenously administered ribavirinT H Kramer, G G Gaar, C G Ray, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouseE A Ayres, D N Parkhurst, S Fang, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
The effects of a centrally selective cholecystokinin analog on male, Sprague Dawley rats in the non-fasted food intake modelW S Wire, S N Fang, V J Hruby, et al.
Life Sciences|January 1, 1992
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphinA Misicka, A W Lipkowski, R Horvath, et al.
Life Sciences|January 1, 1991
Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitroT H Kramer, G Toth, R C Haaseth, et al.
Journal of Medicinal Chemistry|January 1, 1990
[D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptorsG Toth, T H Kramer, R Knapp, et al.
Proceedings of the Western Pharmacology Society|January 1, 1990
Evaluation of a food intake model as a tool for studying cholecystokinin (CCK) and derivatives of CCK in male Sprague-Dawley ratsW S Wire, S N Fang, V J Hruby, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivoT H Kramer, J E Shook, W Kazmierski, et al.
Gastroenterology|June 1, 1991
Changes in opioid receptor selectivity following processing of peptide E: effect on gut motilityT P Davis, T J Gillespie, J Shook, et al.
International Journal of Peptide and Protein Research|February 1, 1992
Synthesis and biological activities of linear and cyclic enkephalin analogues containing a psi (E,CH = CH) or psi (CH2CH2) isosteric replacementD Tourwé, J Couder, M Ceusters, et al.
Pageof 6